Pharma & Healthcare
Global Enasidenib Market Research Report 2025
- Sep 09, 25
- ID: 497385
- Pages: 74
- Figures: 67
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enasidenib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enasidenib.
The Enasidenib market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enasidenib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enasidenib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Segment by Type
50mg
100mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enasidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enasidenib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Enasidenib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enasidenib.
The Enasidenib market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enasidenib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enasidenib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol Myers Squibb
Segment by Type
50mg
100mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enasidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enasidenib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Enasidenib Market Overview
1.1 Product Definition
1.2 Enasidenib by Type
1.2.1 Global Enasidenib Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 100mg
1.3 Enasidenib by Application
1.3.1 Global Enasidenib Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Enasidenib Market Size Estimates and Forecasts
1.4.1 Global Enasidenib Revenue 2020-2031
1.4.2 Global Enasidenib Sales 2020-2031
1.4.3 Global Enasidenib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Enasidenib Market Competition by Manufacturers
2.1 Global Enasidenib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Enasidenib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Enasidenib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Enasidenib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enasidenib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enasidenib, Product Type & Application
2.7 Global Key Manufacturers of Enasidenib, Date of Enter into This Industry
2.8 Global Enasidenib Market Competitive Situation and Trends
2.8.1 Global Enasidenib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enasidenib Players Market Share by Revenue
2.8.3 Global Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enasidenib Market Scenario by Region
3.1 Global Enasidenib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Enasidenib Sales by Region: 2020-2031
3.2.1 Global Enasidenib Sales by Region: 2020-2025
3.2.2 Global Enasidenib Sales by Region: 2026-2031
3.3 Global Enasidenib Revenue by Region: 2020-2031
3.3.1 Global Enasidenib Revenue by Region: 2020-2025
3.3.2 Global Enasidenib Revenue by Region: 2026-2031
3.4 North America Enasidenib Market Facts & Figures by Country
3.4.1 North America Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Enasidenib Sales by Country (2020-2031)
3.4.3 North America Enasidenib Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Enasidenib Market Facts & Figures by Country
3.5.1 Europe Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Enasidenib Sales by Country (2020-2031)
3.5.3 Europe Enasidenib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enasidenib Market Facts & Figures by Region
3.6.1 Asia Pacific Enasidenib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Enasidenib Sales by Region (2020-2031)
3.6.3 Asia Pacific Enasidenib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enasidenib Market Facts & Figures by Country
3.7.1 Latin America Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Enasidenib Sales by Country (2020-2031)
3.7.3 Latin America Enasidenib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enasidenib Market Facts & Figures by Country
3.8.1 Middle East and Africa Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Enasidenib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Enasidenib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enasidenib Sales by Type (2020-2031)
4.1.1 Global Enasidenib Sales by Type (2020-2025)
4.1.2 Global Enasidenib Sales by Type (2026-2031)
4.1.3 Global Enasidenib Sales Market Share by Type (2020-2031)
4.2 Global Enasidenib Revenue by Type (2020-2031)
4.2.1 Global Enasidenib Revenue by Type (2020-2025)
4.2.2 Global Enasidenib Revenue by Type (2026-2031)
4.2.3 Global Enasidenib Revenue Market Share by Type (2020-2031)
4.3 Global Enasidenib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Enasidenib Sales by Application (2020-2031)
5.1.1 Global Enasidenib Sales by Application (2020-2025)
5.1.2 Global Enasidenib Sales by Application (2026-2031)
5.1.3 Global Enasidenib Sales Market Share by Application (2020-2031)
5.2 Global Enasidenib Revenue by Application (2020-2031)
5.2.1 Global Enasidenib Revenue by Application (2020-2025)
5.2.2 Global Enasidenib Revenue by Application (2026-2031)
5.2.3 Global Enasidenib Revenue Market Share by Application (2020-2031)
5.3 Global Enasidenib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol Myers Squibb Enasidenib Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enasidenib Industry Chain Analysis
7.2 Enasidenib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enasidenib Production Mode & Process Analysis
7.4 Enasidenib Sales and Marketing
7.4.1 Enasidenib Sales Channels
7.4.2 Enasidenib Distributors
7.5 Enasidenib Customer Analysis
8 Enasidenib Market Dynamics
8.1 Enasidenib Industry Trends
8.2 Enasidenib Market Drivers
8.3 Enasidenib Market Challenges
8.4 Enasidenib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Enasidenib by Type
1.2.1 Global Enasidenib Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 100mg
1.3 Enasidenib by Application
1.3.1 Global Enasidenib Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Enasidenib Market Size Estimates and Forecasts
1.4.1 Global Enasidenib Revenue 2020-2031
1.4.2 Global Enasidenib Sales 2020-2031
1.4.3 Global Enasidenib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Enasidenib Market Competition by Manufacturers
2.1 Global Enasidenib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Enasidenib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Enasidenib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Enasidenib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enasidenib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enasidenib, Product Type & Application
2.7 Global Key Manufacturers of Enasidenib, Date of Enter into This Industry
2.8 Global Enasidenib Market Competitive Situation and Trends
2.8.1 Global Enasidenib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enasidenib Players Market Share by Revenue
2.8.3 Global Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enasidenib Market Scenario by Region
3.1 Global Enasidenib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Enasidenib Sales by Region: 2020-2031
3.2.1 Global Enasidenib Sales by Region: 2020-2025
3.2.2 Global Enasidenib Sales by Region: 2026-2031
3.3 Global Enasidenib Revenue by Region: 2020-2031
3.3.1 Global Enasidenib Revenue by Region: 2020-2025
3.3.2 Global Enasidenib Revenue by Region: 2026-2031
3.4 North America Enasidenib Market Facts & Figures by Country
3.4.1 North America Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Enasidenib Sales by Country (2020-2031)
3.4.3 North America Enasidenib Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Enasidenib Market Facts & Figures by Country
3.5.1 Europe Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Enasidenib Sales by Country (2020-2031)
3.5.3 Europe Enasidenib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enasidenib Market Facts & Figures by Region
3.6.1 Asia Pacific Enasidenib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Enasidenib Sales by Region (2020-2031)
3.6.3 Asia Pacific Enasidenib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enasidenib Market Facts & Figures by Country
3.7.1 Latin America Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Enasidenib Sales by Country (2020-2031)
3.7.3 Latin America Enasidenib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enasidenib Market Facts & Figures by Country
3.8.1 Middle East and Africa Enasidenib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Enasidenib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Enasidenib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enasidenib Sales by Type (2020-2031)
4.1.1 Global Enasidenib Sales by Type (2020-2025)
4.1.2 Global Enasidenib Sales by Type (2026-2031)
4.1.3 Global Enasidenib Sales Market Share by Type (2020-2031)
4.2 Global Enasidenib Revenue by Type (2020-2031)
4.2.1 Global Enasidenib Revenue by Type (2020-2025)
4.2.2 Global Enasidenib Revenue by Type (2026-2031)
4.2.3 Global Enasidenib Revenue Market Share by Type (2020-2031)
4.3 Global Enasidenib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Enasidenib Sales by Application (2020-2031)
5.1.1 Global Enasidenib Sales by Application (2020-2025)
5.1.2 Global Enasidenib Sales by Application (2026-2031)
5.1.3 Global Enasidenib Sales Market Share by Application (2020-2031)
5.2 Global Enasidenib Revenue by Application (2020-2031)
5.2.1 Global Enasidenib Revenue by Application (2020-2025)
5.2.2 Global Enasidenib Revenue by Application (2026-2031)
5.2.3 Global Enasidenib Revenue Market Share by Application (2020-2031)
5.3 Global Enasidenib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol Myers Squibb Enasidenib Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enasidenib Industry Chain Analysis
7.2 Enasidenib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enasidenib Production Mode & Process Analysis
7.4 Enasidenib Sales and Marketing
7.4.1 Enasidenib Sales Channels
7.4.2 Enasidenib Distributors
7.5 Enasidenib Customer Analysis
8 Enasidenib Market Dynamics
8.1 Enasidenib Industry Trends
8.2 Enasidenib Market Drivers
8.3 Enasidenib Market Challenges
8.4 Enasidenib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Enasidenib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Enasidenib Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Enasidenib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Enasidenib Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Enasidenib Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Enasidenib Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Enasidenib Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Enasidenib Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Enasidenib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enasidenib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enasidenib, Product Type & Application
Table 12. Global Key Manufacturers of Enasidenib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enasidenib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enasidenib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Enasidenib Sales by Region (2020-2025) & (Units)
Table 18. Global Enasidenib Sales Market Share by Region (2020-2025)
Table 19. Global Enasidenib Sales by Region (2026-2031) & (Units)
Table 20. Global Enasidenib Sales Market Share by Region (2026-2031)
Table 21. Global Enasidenib Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Enasidenib Revenue Market Share by Region (2020-2025)
Table 23. Global Enasidenib Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Enasidenib Revenue Market Share by Region (2026-2031)
Table 25. North America Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Enasidenib Sales by Country (2020-2025) & (Units)
Table 27. North America Enasidenib Sales by Country (2026-2031) & (Units)
Table 28. North America Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Enasidenib Sales by Country (2020-2025) & (Units)
Table 32. Europe Enasidenib Sales by Country (2026-2031) & (Units)
Table 33. Europe Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Enasidenib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Enasidenib Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Enasidenib Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Enasidenib Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Enasidenib Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Enasidenib Sales by Country (2020-2025) & (Units)
Table 42. Latin America Enasidenib Sales by Country (2026-2031) & (Units)
Table 43. Latin America Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Enasidenib Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Enasidenib Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Enasidenib Sales (Units) by Type (2020-2025)
Table 51. Global Enasidenib Sales (Units) by Type (2026-2031)
Table 52. Global Enasidenib Sales Market Share by Type (2020-2025)
Table 53. Global Enasidenib Sales Market Share by Type (2026-2031)
Table 54. Global Enasidenib Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Enasidenib Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Enasidenib Revenue Market Share by Type (2020-2025)
Table 57. Global Enasidenib Revenue Market Share by Type (2026-2031)
Table 58. Global Enasidenib Price (USD/Unit) by Type (2020-2025)
Table 59. Global Enasidenib Price (USD/Unit) by Type (2026-2031)
Table 60. Global Enasidenib Sales (Units) by Application (2020-2025)
Table 61. Global Enasidenib Sales (Units) by Application (2026-2031)
Table 62. Global Enasidenib Sales Market Share by Application (2020-2025)
Table 63. Global Enasidenib Sales Market Share by Application (2026-2031)
Table 64. Global Enasidenib Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Enasidenib Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Enasidenib Revenue Market Share by Application (2020-2025)
Table 67. Global Enasidenib Revenue Market Share by Application (2026-2031)
Table 68. Global Enasidenib Price (USD/Unit) by Application (2020-2025)
Table 69. Global Enasidenib Price (USD/Unit) by Application (2026-2031)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Enasidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Bristol Myers Squibb Enasidenib Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Enasidenib Distributors List
Table 78. Enasidenib Customers List
Table 79. Enasidenib Market Trends
Table 80. Enasidenib Market Drivers
Table 81. Enasidenib Market Challenges
Table 82. Enasidenib Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Product Picture of Enasidenib
Figure 2. Global Enasidenib Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Enasidenib Market Share by Type: 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Enasidenib Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Enasidenib Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Enasidenib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Enasidenib Market Size (2020-2031) & (US$ Million)
Figure 12. Global Enasidenib Sales (2020-2031) & (Units)
Figure 13. Global Enasidenib Average Price (USD/Unit) & (2020-2031)
Figure 14. Enasidenib Report Years Considered
Figure 15. Enasidenib Sales Share by Manufacturers in 2024
Figure 16. Global Enasidenib Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Enasidenib Players: Market Share by Revenue in Enasidenib in 2024
Figure 18. Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Enasidenib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Enasidenib Sales Market Share by Country (2020-2031)
Figure 21. North America Enasidenib Revenue Market Share by Country (2020-2031)
Figure 22. the United States Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Enasidenib Sales Market Share by Country (2020-2031)
Figure 25. Europe Enasidenib Revenue Market Share by Country (2020-2031)
Figure 26. Germany Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Enasidenib Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Enasidenib Revenue Market Share by Region (2020-2031)
Figure 33. China Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Enasidenib Sales Market Share by Country (2020-2031)
Figure 43. Latin America Enasidenib Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Enasidenib Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Enasidenib Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Enasidenib by Type (2020-2031)
Figure 53. Global Revenue Market Share of Enasidenib by Type (2020-2031)
Figure 54. Global Enasidenib Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Enasidenib by Application (2020-2031)
Figure 56. Global Revenue Market Share of Enasidenib by Application (2020-2031)
Figure 57. Global Enasidenib Price (USD/Unit) by Application (2020-2031)
Figure 58. Enasidenib Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Enasidenib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Enasidenib Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Enasidenib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Enasidenib Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Enasidenib Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Enasidenib Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Enasidenib Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Enasidenib Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Enasidenib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enasidenib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enasidenib, Product Type & Application
Table 12. Global Key Manufacturers of Enasidenib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enasidenib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enasidenib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Enasidenib Sales by Region (2020-2025) & (Units)
Table 18. Global Enasidenib Sales Market Share by Region (2020-2025)
Table 19. Global Enasidenib Sales by Region (2026-2031) & (Units)
Table 20. Global Enasidenib Sales Market Share by Region (2026-2031)
Table 21. Global Enasidenib Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Enasidenib Revenue Market Share by Region (2020-2025)
Table 23. Global Enasidenib Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Enasidenib Revenue Market Share by Region (2026-2031)
Table 25. North America Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Enasidenib Sales by Country (2020-2025) & (Units)
Table 27. North America Enasidenib Sales by Country (2026-2031) & (Units)
Table 28. North America Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Enasidenib Sales by Country (2020-2025) & (Units)
Table 32. Europe Enasidenib Sales by Country (2026-2031) & (Units)
Table 33. Europe Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Enasidenib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Enasidenib Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Enasidenib Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Enasidenib Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Enasidenib Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Enasidenib Sales by Country (2020-2025) & (Units)
Table 42. Latin America Enasidenib Sales by Country (2026-2031) & (Units)
Table 43. Latin America Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Enasidenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Enasidenib Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Enasidenib Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Enasidenib Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Enasidenib Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Enasidenib Sales (Units) by Type (2020-2025)
Table 51. Global Enasidenib Sales (Units) by Type (2026-2031)
Table 52. Global Enasidenib Sales Market Share by Type (2020-2025)
Table 53. Global Enasidenib Sales Market Share by Type (2026-2031)
Table 54. Global Enasidenib Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Enasidenib Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Enasidenib Revenue Market Share by Type (2020-2025)
Table 57. Global Enasidenib Revenue Market Share by Type (2026-2031)
Table 58. Global Enasidenib Price (USD/Unit) by Type (2020-2025)
Table 59. Global Enasidenib Price (USD/Unit) by Type (2026-2031)
Table 60. Global Enasidenib Sales (Units) by Application (2020-2025)
Table 61. Global Enasidenib Sales (Units) by Application (2026-2031)
Table 62. Global Enasidenib Sales Market Share by Application (2020-2025)
Table 63. Global Enasidenib Sales Market Share by Application (2026-2031)
Table 64. Global Enasidenib Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Enasidenib Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Enasidenib Revenue Market Share by Application (2020-2025)
Table 67. Global Enasidenib Revenue Market Share by Application (2026-2031)
Table 68. Global Enasidenib Price (USD/Unit) by Application (2020-2025)
Table 69. Global Enasidenib Price (USD/Unit) by Application (2026-2031)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Enasidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Bristol Myers Squibb Enasidenib Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Enasidenib Distributors List
Table 78. Enasidenib Customers List
Table 79. Enasidenib Market Trends
Table 80. Enasidenib Market Drivers
Table 81. Enasidenib Market Challenges
Table 82. Enasidenib Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Product Picture of Enasidenib
Figure 2. Global Enasidenib Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Enasidenib Market Share by Type: 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Enasidenib Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Enasidenib Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Enasidenib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Enasidenib Market Size (2020-2031) & (US$ Million)
Figure 12. Global Enasidenib Sales (2020-2031) & (Units)
Figure 13. Global Enasidenib Average Price (USD/Unit) & (2020-2031)
Figure 14. Enasidenib Report Years Considered
Figure 15. Enasidenib Sales Share by Manufacturers in 2024
Figure 16. Global Enasidenib Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Enasidenib Players: Market Share by Revenue in Enasidenib in 2024
Figure 18. Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Enasidenib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Enasidenib Sales Market Share by Country (2020-2031)
Figure 21. North America Enasidenib Revenue Market Share by Country (2020-2031)
Figure 22. the United States Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Enasidenib Sales Market Share by Country (2020-2031)
Figure 25. Europe Enasidenib Revenue Market Share by Country (2020-2031)
Figure 26. Germany Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Enasidenib Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Enasidenib Revenue Market Share by Region (2020-2031)
Figure 33. China Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Enasidenib Sales Market Share by Country (2020-2031)
Figure 43. Latin America Enasidenib Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Enasidenib Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Enasidenib Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Enasidenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Enasidenib by Type (2020-2031)
Figure 53. Global Revenue Market Share of Enasidenib by Type (2020-2031)
Figure 54. Global Enasidenib Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Enasidenib by Application (2020-2031)
Figure 56. Global Revenue Market Share of Enasidenib by Application (2020-2031)
Figure 57. Global Enasidenib Price (USD/Unit) by Application (2020-2031)
Figure 58. Enasidenib Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232